Head and Neck Cancer Partnering 2007-2013

NAVI MUMBAI, India - July 15, 2013 - PRLog -- Jul 15,2013 : Bharat Book Bureau presents the new report, on 'Head and Neck Cancer Partnering' The report provides an analysis of head and neck cancer partnering deals.

Summary

The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors head and neck cancer technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This data driven report contains over 30 links to online copies of actual head and neck cancer deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

The initial chapters of this report provide an orientation of  head and neck cancer partnering (http://www.bharatbook.com/healthcare-market-research-repo...) trends.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in head and neck cancer partnering since 2007, including a summary of deals by industry sector, stage of development, deal type, and technology type. Numerous tables provide outline financial trends.
Chapter 3 provides an overview of the leading head and neck cancer deals since 2007. Deals are listed by headline value, signed by bigpharma, most active bigpharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
Chapter 4 provides a comprehensive directory of head and neck cancer partnering deals signed and announced since 2007. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the
research, development and commercialization of head and neck cancer technologies and products.

Report scope

Head and Neck Cancer Partnering 2007-2013 is intended to provide the reader with an in-depth understanding and access to head and neck cancer trends and structure of deals entered into by leading companies worldwide.

This data driven report includes:

Trends in head and neck cancer dealmaking in the biopharma industry since 2007
Access to summary headline, upfront, milestone and royalty data
Access to over 30 head and neck cancer contract documents
The leading head and neck cancer deals by value since 2007
In Head and Neck Cancer Partnering 2007-2013, the available deals are listed by:

Headline value
Upfront payment value
Royalty rate value
Company A-Z
Industry sector
Stage of development at signing
Deal component type
Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Head and Neck Cancer Partnering 2007-2013 provides the reader with the following key benefits:

In-depth understanding of head and neck cancer deal trends since 2007
Access to summary headline, upfront, milestone and royalty data
Comprehensive access to over 30 actual head and neck cancer deals entered into by the world’s biopharma companies since 2007
Insight into key deal terms included in contracts, where disclosed
Understand the key deal terms companies have agreed in deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies

For more information kindly visit :  http://www.bharatbook.com/healthcare-market-research-reports/head-and-neck-cancer-partnering-2007-2013.html

About Bharat Book Bureau:

Bharat Book Bureau is the leading market research information provider for market research (http://www.bharatbook.com), company profiles, industry analysis , country reports , business reports, newsletters and online databases  Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.

In case the reports don’t match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself.

Contact us at :  

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Toll Free No for USA/Canada : 1-866-279-8368
Call UK +44 7405 208461
Email: info@bharatbook.com  
Website: www.bharatbook.com